Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.

Matilde Todaro, Campesi, Gloria Invernici, Gadau, Ward, Graiani, Van Linthout, Spillmann, Costanza Emanueli, Meloni, Paolo Madeddu

Risultato della ricerca: Article

65 Citazioni (Scopus)

Abstract

Benfotiamine, a vitamin B1 analogue, reportedly prevents diabetic microangiopathy. The aim of this study was to evaluate whether benfotiamine is of benefit in reparative neovascularisation using a type I diabetes model of hindlimb ischaemia. We also investigated the involvement of protein kinase B (PKB)/Akt in the therapeutic effects of benfotiamine.
Lingua originaleEnglish
pagine (da-a)405-420
Numero di pagine16
RivistaDiabetologia
Volume49
Stato di pubblicazionePublished - 2006

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cita questo

Todaro, M., Campesi, Invernici, G., Gadau, Ward, Graiani, Van Linthout, Spillmann, Emanueli, C., Meloni, & Madeddu, P. (2006). Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. Diabetologia, 49, 405-420.